Bausch Health
BHC
#4001
Rank
S$3.02 B
Marketcap
$8.21
Share price
-2.24%
Change (1 day)
-40.41%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$3.58

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$3.57. In 2022 the company made an earnings per share (EPS) of -$0.83 an increase over its 2021 EPS that were of -$3.57.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.58328.96%
2022-$0.83-76.64%
2021-$3.5768.45%
2020-$2.12-68.91%
2019-$6.82-57.11%
2018-$15.91-272.22%
2017$9.24-199.29%
2016-$9.30798.7%
2015-$1.04-128.31%
2014$3.66-204.62%
2013-$3.50602.7%
2012-$0.50-171.15%
2011$0.70-143.96%
2010-$1.59-206.57%
2009$1.49-11.2%
2008$1.682.46%
2007$1.64-7.58%
2006$1.77-14.29%
2005$2.0754%
2004$1.34-500%
2003-$0.34-141.67%
2002$0.81-4.76%
2001$0.85-175%
2000-$1.13-268%
1999$0.6714.94%
1998$0.5820.83%
1997$0.4853.83%
1996$0.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.34-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.36-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA